About ABK Biomedical
ABK Biomedical is committed to research, develop, and commercialize breakthrough medical device therapies to improve treatment outcomes and the lives of patients with liver tumors.
Founded in 2012, we are focused on researching, developing, and commercializing breakthrough medical device therapies to improve treatment outcomes and the lives of patients with benign and malignant hypervascular tumors.
With our multi-disciplinary experience in engineering, material science, oncology, medical science, regulatory, finance, business development, sales, marketing, and clinical study coordination we are staffed with the talent to drive the next level of technology for personalized healthcare in oncology.
A novel technology for Y90 radioembolization made with a proprietary, radiopaque glass composition for in-procedure visualization.
Easi-Vue™ embolic microspheres
Radiopaque bland embolization product allowing direct visualization at the target site.
Who we are
The Leadership Team is dedicated to leading the teams that research, develop and manufacture state-of-the-art medical device technologies to treat liver cancers and hypervascular tumors.
We also maintain a future vision of expanded human-body applications for our radioembolization and bland embolotherapy therapies for continuous improvement of patient outcomes.
Founded at Dalhousie University in 2012, The Three Founders; Doctor’s Robert Abraham, Daniel Boyd and Sharon Kehoe developed, engineered and patented proprietary x-ray visible glass microspheres to improve embolotherapy patient outcomes.
To support this advancing technology, we assembled an expert, multidisciplinary senior management team and invested in expanded R&D and manufacturing facilities. ABK Biomedical raised $30M USD in Series B funding in 2019, the largest medical venture capital raise in Atlantic Canada.
Working at ABK Biomedical
ABK Biomedical is dedicated to providing a stimulating work environment that offers growth opportunities, employee benefits, and exciting career challenges.
We accomplish our mandate through multi-disciplinary teams experienced in engineering, material science, oncology, medical science, regulatory, finance, business development, sales, marketing, and clinical study coordination.
The ABK Biomedical Team
We are dedicated to encouraging a stimulating work environment offering an opportunity to significantly expand experience and skills by researching, developing, and commercializing cutting-edge medical device technologies with a mandate to effectively treat cancer.
ABK Biomedical is an equal opportunity employer offering competitive compensation packages.
ABK's Business Partners
ABK Biomedical is proud to partner with cutting-edge organizations and individuals with exceptional skills, scientific expertise, and the highest business ethics.
Halifax Office (Main Office)
155 Chain Lake Drive
Halifax, NS B3S 1B3
Orange County Office
555 Corporate Drive
Ladera Ranch, CA, 92694
ABK Biomedical Inc. provides and continues to provide accurate information on its website. However, ABK Biomedical Inc. assumes no responsibility for the accuracy and/or completeness, express or implied, as to the information contained or omitted and/or the products described. Furthermore, ABK Biomedical Inc. may change the products mentioned, and their stage in development, at any time without notice. ABK Biomedical Inc. is a clinical-stage company engaged in the research and development of new medical devices. Eye90 microspheres® is considered an investigational product and is NOT FDA-approved for use.
Copyright 2022 - All International Rights Reserved